The age of the GLP-1 drug has reached yet another milestone, with the US Food and Drug Administration green-lighting Novo Nordisk's once-daily oral semaglutide pill to treat people at high risk of ...

In a case that was billed as profits versus patients, India’s Supreme Court dismissed a petition in which Roche sought to ...

The FDA announced the first nine recipients of the Commissioner’s National Priority Review vouchers, a program offering an ...

US pharmaceutical giant Eli Lilly unveils plans to invest over $1 billion in India, marking a significant infusion into the ...

While Ashley McEvoy has only been at the helm of Insulet for five months, she's already seeing the increasing role of AI in ...

NEW DELHI- The dramatic rise in diabetes and obesity among Indians is being driven by rapidly changing eating habits marked by a high intake of carbohydrates and saturated fat, alongside low protein ...

In this segment of 5 Live, the focus is on the Indian drug regulator CDSCO's approval of the blockbuster drug Ozempic. It is cleared for treating type 2 diabetes and reducing risks of serious heart ...

Kourtnee covers TV streaming services and home entertainment. She previously worked as an entertainment reporter at Showbiz Cheat Sheet, where she wrote about film, television, music, celebrities and ...

VISAKHAPATNAM, India — America's love affair with shrimp is a cultural touchstone, enough that The Daily Show could air multiple segments out of Red Lobster's $11 million loss after it offered a $20 ...

The H-1B visa lured a generation of Indian professionals to take part in the American dream. A $100,000 fee has forced a rethink of the route. By Alex Travelli Reporting from New Delhi Some of the ...

Over the last six years, three GLP-1 drugs have been approved for children aged 10 and older with Type 2 diabetes. Now this rapidly growing patient population is a step closer to gaining access to Eli ...